Literature DB >> 14642439

Increased TNFalpha production and Cox-2 activity in organotypic brain slice cultures from APPsw transgenic mice.

Amita Quadros1, Nikunj Patel, Robert Crescentini, Fiona Crawford, Daniel Paris, Michael Mullan.   

Abstract

beta-Amyloid (Abeta) peptides are the principal component of senile plaques and vascular deposits in Alzheimer's disease and are derived from the proteolytic cleavage of the beta-amyloid precursor protein (APP). We have previously shown that synthetic Abeta can stimulate cyclooxygenase-2 (Cox-2) activity in brain organotypic slice cultures. In the present study, we used brain slices from transgenic APP Swedish (TgAPPsw) mice and control littermates of different age groups to determine the effect of APP overexpression on the levels of prostaglandin and tumor necrosis factor alpha (TNFalpha) release. The production of eicosanoid and TNFalpha was increased as a function of age in organotypic brain slice culture from TgAPPsw mice compared to age matched control littermates. We also showed that the selective Cox-2 inhibitor NS-398 reduces the production of eicosanoid and TNFalpha in organotypic brain slice cultures of TgAPPsw mice. In conclusion, our data suggest that either activity or expression of Cox-2 is increased in TgAPPsw mice brains as a function of age, contributing to an increased production of pro-inflammatory eicosanoids and TNFalpha.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14642439     DOI: 10.1016/j.neulet.2003.08.076

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Antagonism of neuronal prostaglandin E(2) receptor subtype 1 mitigates amyloid β neurotoxicity in vitro.

Authors:  Xianwu Li; Shannon E Rose; Kathleen S Montine; C Dirk Keene; Thomas J Montine
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-21       Impact factor: 4.147

2.  Regional protein levels of cytosolic phospholipase A2 and cyclooxygenase-2 in Rhesus monkey brain as a function of age.

Authors:  Gayani R Weerasinghe; Steven L Coon; Abesh Kumar Bhattacharjee; G Jean Harry; Francesca Bosetti
Journal:  Brain Res Bull       Date:  2006-03-30       Impact factor: 4.077

3.  α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.

Authors:  Dylan Shea; Cheng-Chieh Hsu; Timothy M Bi; Natasha Paranjapye; Matthew Carter Childers; Joshua Cochran; Colson P Tomberlin; Libo Wang; Daniel Paris; Jeffrey Zonderman; Gabriele Varani; Christopher D Link; Mike Mullan; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-19       Impact factor: 11.205

Review 4.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

5.  Synergism in the repression of COX-2- and TNFalpha-induction in platelet activating factor-stressed human neural cells.

Authors:  Anja Boetkjaer; Merete Boedker; Jian-Guo Cui; Yuhai Zhao; Walter J Lukiw
Journal:  Neurosci Lett       Date:  2007-08-31       Impact factor: 3.046

Review 6.  Molecular rationale for the pharmacological treatment of Alzheimer's disease.

Authors:  Martina Zimmermann; Fabrizio Gardoni; Monica Di Luca
Journal:  Drugs Aging       Date:  2005       Impact factor: 4.271

7.  Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease.

Authors:  Nikunj S Patel; Daniel Paris; Venkatarajan Mathura; Amita N Quadros; Fiona C Crawford; Michael J Mullan
Journal:  J Neuroinflammation       Date:  2005-03-11       Impact factor: 8.322

8.  YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2.

Authors:  Zheng-Yi Li; Yoon Hee Chung; Eun-Joo Shin; Duy-Khanh Dang; Ji Hoon Jeong; Sung Kwon Ko; Seung-Yeol Nah; Tae Gon Baik; Jin Hyeong Jhoo; Wei-Yi Ong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2017-04-27       Impact factor: 8.322

9.  Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain.

Authors:  J S Rao; S I Rapoport; H-W Kim
Journal:  Transl Psychiatry       Date:  2011-08-16       Impact factor: 6.222

Review 10.  Organotypic brain slice cultures: A review.

Authors:  C Humpel
Journal:  Neuroscience       Date:  2015-08-05       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.